SCHEMBL1436243

SCHEMBL1436243

Fc1c(F)c(C(F)(F)F)c(F)c(F)c1S

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28844445 0.94 TSHR (0.33) SMN1; SMN2TSHR
SCHEMBL28230690 0.91 TSHR (0.30) SMN1; SMN2TSHR
SCHEMBL312355 0.83 SMN1; SMN2 (0.42) SMN1; SMN2TSHRMEN1KMT2A
Perfluorotoluene SCHEMBL308464 0.79 SMN1; SMN2 (0.41) SMN1; SMN2TSHRMEN1KMT2A
Perfluorotoluene SCHEMBL28273865 0.76 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMEN1KMT2A
Perfluorotoluene SCHEMBL28760715 0.76 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL3168128 0.76 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL1998599 0.75 SMN1; SMN2 (0.37) SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL1972987 0.75
SCHEMBL24254677 0.73 SMN1; SMN2 (0.38) SMN1; SMN2TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260123372-A1 MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-30 US claimed
US-12518966-B2 Selective plasma enhanced atomic layer deposition VERSUM MATERIALS US, LLC (US) 2026-01-06 US claimed
US-20240047196-A1 SELECTIVE THERMAL ATOMIC LAYER DEPOSITION VERSUM MAT US LLC (US) 2024-02-08 US claimed
US-20240014036-A1 SELECTIVE PLASMA ENHANCED ATOMIC LAYER DEPOSITION VERSUM MATERIALS US, LLC 2024-01-11 US claimed
US-20230416911-A1 SELECTIVE DEPOSITION OF SILICON AND OXYGEN CONTAINING DIELECTRIC FILM ON DIELECTRICS VERSUM MATERIALS US, LLC 2023-12-28 US claimed
CN-116918029-A selective thermal atomic layer deposition 弗萨姆材料美国有限责任公司 2023-10-20 CN claimed
CN-116761906-A Selective plasma enhanced atomic layer deposition 弗萨姆材料美国有限责任公司 2023-09-15 CN claimed
EP-4240886-A1 SELECTIVE PLASMA ENHANCED ATOMIC LAYER DEPOSITION Versum Materials US, LLC (US) 2023-09-13 EP claimed
EP-4241299-A1 SELECTIVE THERMAL ATOMIC LAYER DEPOSITION Versum Materials US, LLC (US) 2023-09-13 EP claimed
WO-2022119860-A9 SELECTIVE THERMAL ATOMIC LAYER DEPOSITION VERSUM MATERIAL US, LLC (US) 2023-08-24 WO claimed
US-20180351121-A1 HYBRID HALIDE PEROVSKITE-BASED FIELD EFFECT TRANSISTORS WAKE FOREST UNIVERSITY (US) 2018-12-06 US claimed
US-9815809-B2 Formation of chiral 4-chromanones using chiral pyrrolidines in the presence of phenols or thiophenols DSM IP ASSETS B.V. (NL) 2017-11-14 US claimed
CN-105358541-B Chiral 4 benzodihydropyrone is formed using chiral pyrrolidine in the presence of phenol or thiophenol 帝斯曼知识产权资产管理有限公司 2017-11-03 CN claimed
WO-2017083408-A1 HYBRID HALIDE PEROVSKITE-BASED FIELD EFFECT TRANSISTORS WAKE FOREST UNIVERSITY (US) 2017-05-18 WO claimed
US-20170130085-A1 CONDUCTOR COMPOSITION INK, CONDUCTOR, LAMINATE, LAMINATED WIRING BOARD AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-05-11 US claimed
EP-3016940-B1 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS DSM IP ASSETS BV (NL) 2017-04-12 EP claimed
CN-106459640-A Conductor composition ink, conductor, laminate, laminated wiring board, and electronic device 出光兴产株式会社 2017-02-22 CN claimed
US-20160168111-A1 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS DSM IP ASSETS B.V. (NL) 2016-06-16 US claimed
EP-3016940-A1 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS DSM IP Assets B.V. (NL) 2016-05-11 EP claimed
WO-2015001029-A1 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS DSM IP ASSETS B.V. (NL) 2015-01-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168111-A1 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS CYP4B1, CYP4F3, CYP4F2 SMN1; SMN2 4878/4885TSHR 2008/4885MEN1 4707/4885
US-20260123372-A1 MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS PDK1, HPD, HAO2 SMN1; SMN2 3762/4885TSHR 4501/4885MEN1 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.